Inspira Tech OXY

IINN

----

Current ValuationThe current P/E ratio is -1.23, within the reasonable range, cheaper than 22.48% of the time in the past 3 years, and the industry ranks 89/174, the industry Median -0.89.

-1.23xP/E

Stock price--

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

012243648

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-11.66x	141.71%	$12.39B
GKOSUSGlaukos	-54.01x	75.37%	$10.16B
TFXUSTeleflex	-5.11x	118.39%	$5.27B
PLSEUSPulse Biosciences	-43.73x	27.55%	$3.50B
IRTCUSIRhythm	-248.14x	70.88%	$3.46B
BFLYUSButterfly Network	-29.42x	34.41%	$2.20B
AXGNUSAxogen	-63.03x	18.38%	$2.11B
ASSTUSStrive	-2.00x	63.23%	$1.95B
NVCRUSNovocure	-11.49x	1.23%	$1.71B
ATECUSAlphatec	-14.39x	41.67%	$1.58B
KMTSUSKestra Medical Tech	-10.36x	0.94%	$1.55B
DRTSUSAlpha Tau Medical	-14.21x	--	$1.32B
TNDMUSTandem Diabetes	-17.41x	77.60%	$1.10B
AORTUSArtivion	-330.19x	266.67%	$1.05B
PRCTUSPROCEPT BioRobotics	-9.35x	3.47%	$1.03B
ENOVUSEnovis	-0.92x	100.97%	$1.02B
IARTUSIntegra LifeSciences	-139.70x	109.42%	$1.01B
BBNXUSBeta Bionics	-13.04x	13.22%	$951.76M
CBLLUSCeribell	-13.65x	35.15%	$901.12M
SIBNUSSI-BONE	-58.50x	8.85%	$856.03M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.